Smith, Toby ORCID: https://orcid.org/0000-0003-1673-2954, Maidment, Ian, Hebding, Jennifer, Madzima, Tairo, Cheater, Francine, Cross, Jane
ORCID: https://orcid.org/0000-0002-7003-1916, Poland, Fiona
ORCID: https://orcid.org/0000-0003-0003-6911, White, Jacqueline, Young, John and Fox, Chris
ORCID: https://orcid.org/0000-0001-9480-5704
(2014)
Systematic review investigating the reporting of comorbidities and medication in randomized controlled trials of people with dementia.
Age and Ageing, 43 (6).
pp. 868-872.
ISSN 0002-0729
Abstract
Dementia is a debilitating condition characterised by global loss of cognitive and intellectual functioning, which reduces social and occupational performance. This population frequently presents with medical co-morbidities such as hypertension, cardiovascular disease and diabetes. The CONSORT statement outlines recommended guidance on reporting of participant characteristics in clinical trials. It is, however, unclear how much these are adhered to in trials assessing people with dementia. This paper assesses the reporting of medical co-morbidities and prescribed medications for people with dementia within randomised controlled trial (RCT) reports.
Item Type: | Article |
---|---|
Additional Information: | © The Author 2014. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oup.com |
Uncontrolled Keywords: | cognitive impairment,dementia,co-morbidity,older people,systematic review,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being |
Faculty \ School: | Faculty of Medicine and Health Sciences > School of Health Sciences Faculty of Medicine and Health Sciences > Norwich Medical School |
Depositing User: | Pure Connector |
Date Deposited: | 01 Aug 2014 13:34 |
Last Modified: | 19 Apr 2023 00:15 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/49418 |
DOI: | 10.1093/ageing/afu100 |
Actions (login required)
![]() |
View Item |